STOCK TITAN

[SCHEDULE 13G] GeoVax Labs, Inc. Passive Investment Disclosure (>5%)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

GeoVax Labs, Inc. received a Schedule 13G reporting that Ayrton Capital LLC, Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B, and Waqas Khatri each beneficially own 4,810,451 shares of common stock, or 9.99% of the class as of December 31, 2025.

The reported position consists of 4,810,451 shares of common stock issuable upon exercise of warrants held by the reporting persons, which are subject to 4.99% and 9.99% beneficial ownership blockers. The percentage is based on 43,303,682 GeoVax common shares outstanding as of December 22, 2025.

The reporting persons certify the securities were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of GeoVax Labs, Inc.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Ayrton Capital LLC
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri / Managing Member
Date:02/11/2026
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri / Director
Date:02/11/2026
Waqas Khatri
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri
Date:02/11/2026
Geovax Labs Inc

NASDAQ:GOVXW

GOVXW Rankings

GOVXW Latest News

GOVXW Latest SEC Filings

GOVXW Stock Data

2.35M
Biotechnology
Pharmaceutical Preparations
Link
United States
SMYRNA